Inspire Medical Systems, Inc. , a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA).
Inspire Medical Systems stock last closed at $43.07, up 2.01% from the previous day, and has decreased 69.3% in one year. It has overperformed other stocks in the Medical Devices industry by 0.02 percentage points. Inspire Medical Systems stock is currently +8.74% from its 52-week low of $39.61, and -70.71% from its 52-week high of $147.03.
There are currently 28.81M INSP shares outstanding. The market capitalization of INSP is $1.24B. In the last 24 hours, 634,000 INSP shares were traded.
How to Buy Inspire Medical Systems Stock
Not sure how to invest in Inspire Medical Systems stock? Here's how.
Choose where to buy Inspire Medical Systems stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Inspire Medical Systems stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Put funds into your investment account: Select your payment method and add your info.
Analyze Inspire Medical Systems stock: The Inspire Medical Systems ticker symbol is INSP. Is Inspire Medical Systems stock a good investment? Should you buy shares of INSP? How do INSP's underlying business fundamentals look? Do top analysts think Inspire Medical Systems is a good buy? Why has INSP's stock price moved recently? (Hint: Our stock research website can help you decide if INSP is a good stock to buy).
Make your INSP trade: Decide if you will purchase INSP shares at the current market price or use a limit order to purchase INSP stock at a given price.
Get notifications regarding your INSP position: Create a watchlist to important notifications about your investment in Inspire Medical Systems stock.
Step 1: Choose where to buy Inspire Medical Systems stock
You need a brokerage account to access the NYSE market and buy INSP shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal information so you can invest in INSP today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Inspire Medical Systems stock
After you have figured out the best place to buy Inspire Medical Systems stock, it's very important to analyze their stock prior to buying, so you truly comprehend the risk as well as the upside.
Overview of key INSP info
INSP Price
$43.07
1w %
-3.73%
1y %
-69.3%
5y %
-77.83%
P/E
9.66x
P/B
1.57x
P/S
1.35x
PEG
N/A
Revenue
$915.25M
Earnings
$131.14M
Fore. Rev. Growth
3.54%
Fore. Earn. Growth
-22.12%
Market Cap
$1.24B
Next Earnings
N/A
Next Dividend
N/A
Inspire Medical Systems Due Diligence Score
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.
There are more short-term assets than long-term liabilities on the INSP balance sheet.
INSP earnings of $64.07M is not sufficient to cover its interest payments.
There are more short-term assets than short-term liabilities on the INSP balance sheet.
INSP profit margin has gone up from 7.9% to 14.3% in the past year.
INSP's operating cash flow of $136.53M allows it to safely service it's debt of $29.55M.
Total INSP debt is lower than 5 years ago, relative to shareholder equity.
Is Inspire Medical Systems stock a Buy, Hold, or Sell, according to analysts?
Out of 13 Wall Street analysts who monitor INSP, the consensus analyst rating on INSP is a Hold
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent INSP Analyst Forecasts
Daniel Markowitz, a bottom 23% analyst from Evercore ISI Group maintains INSP with a buy rating and lowers their INSP price target from $62.00 to $55.00, on May 5, 2026.
Larry Biegelsen, a top 22% analyst from Wells Fargo maintains INSP with a hold rating and lowers their INSP price target from $70.00 to $56.00, on May 5, 2026.
Anthony Petrone, a top 10% analyst from Mizuho maintains INSP with a buy rating and lowers their INSP price target from $70.00 to $55.00, on May 5, 2026.
Mike Polark, a top 31% analyst from Baird maintains INSP with a hold rating and lowers their INSP price target from $63.00 to $50.00, on May 5, 2026.
Michael Sarcone, a bottom 18% analyst from Jefferies maintains INSP with a hold rating and lowers their INSP price target from $81.00 to $66.00, on Feb 12, 2026.
Last year, INSP earnings were $131.14M. In the last one years, INSP's earnings have increased by 99.11% per year. This was faster than the Medical Devices industry average of 21.39%.
Last year, INSP revenue was $915.25M. In the last five year, INSP's revenue has grown by 46.77% per year. This was faster than the Medical Devices industry average of 10.28%.
In the past 12 months, insiders at INSP have sold more shares than they have bought.
John Rondoni, Title Chief Product and Innovation Officer. of INSP, was the latest INSP insider to sell. They sold $114,302.48 worth of INSP stock on May 15, 2026.
No, Inspire Medical Systems doesn't provide an income stream by paying out dividends.
INSP Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your INSP trade
There are two primary options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly the best for newer investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you need more help with investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Inspire Medical Systems share?
As of May 28, 2026, it costs $43.07 to buy one share of Inspire Medical Systems stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.232 shares of INSP.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.